How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis

Intensifying ADT in mHSPC: How to Improve Patient Outcomes and Adherence

How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis

MinuteCE®
ReachMD Healthcare Image
Media formats available:
Details
Episodes
Documents
Presenters
Comments
  • Overview

    This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.

    This program provides information on the most effective implementation of androgen receptor inhibitors (ARIs) to change the disease trajectory for mHSPC. In addition, this education addresses both the challenges of and the need for an interdisciplinary care model that includes oncology pharmacists and nurses who provide patient support and education. Effective interdisciplinary care improves adherence management of adverse effects (AEs) and helps reduce the barriers to access, care, and treatment that contribute to racial and ethnic disparities in prostate cancer treatment. Finally, a patient education solution completes the curriculum, providing clinician-developed videos tethered to and accessible via the HCP education to answer questions frequently faced by patients with prostate cancer.

    Video education created for patients is available for this topic. Visit www.mymededge.com to “prescribe” education that helps patients and caregivers learn more about this condition.

  • Target Audience

    This activity has been designed to meet the educational needs of the interprofessional team, including oncologists, urologists, oncology nurses, and pharmacists involved in the management of patients with metastatic hormone-sensitive prostate cancer (mHSPC).

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Evaluate recent practice-changing clinical trial data and guideline recommendations for ADT intensification in the treatment of patients with mHSPC
    • Implement a shared-decision making approach in practice to inform treatment selection and sequencing to maximize exposure to life-prolonging therapies for patients with mHSPC
    • Explain the roles and responsibilities of oncology pharmacists and nurses in an interdisciplinary care model for patients with mHSPC
    • Incorporate interdisciplinary strategies to reduce barriers to access, care, and treatment that contribute to racial and ethnic disparities in prostate cancer 
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

  • Faculty Disclosure of Commercial Relationships

    Disclosure Policy
    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. 

    The following faculty have disclosed:

    Lisa Holle, PharmD, BCOP, FHOPA, FISOPP, faculty for this educational event, has no relevant financial relationships with ineligible companies.

    Alicia Morgans, MD, MPH, faculty for this educational event, is a contracted researcher for Astellas, Bayer, Lantheus, Myovant, Pfizer, and Sanofi; and receives consulting fees from AAA, Astellas, AstraZeneca, Bayer, Exelixis, Lantheus, Myovant, Myriad Genetics, Novartis, Pfizer, Sanofi, andTelix. 

    Kelvin A. Moses, MD, PhD, FACS, faculty for this educational event, has no relevant financial relationships with ineligible companies.

    Stacy Walker, NP, for this educational event, has no relevant financial relationships with ineligible companies. 

  • Planners and Managers Disclosure List

    The following planners/reviewers/managers have disclosed:

    Elizabeth Lurwick, planner for this educational event, has no relevant financial relationships with ineligible companies.

    Megan Reimann, PharmD, BCOP, planner for this educational event, has no relevant financial relationships with ineligible companies.

    William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.

    Total CME, LLC., planners, and managers have no relevant commercial relationships to disclose.

    All the relevant financial relationships for these individuals have been mitigated.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use their clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go, you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Provider(s)/Educational Partner(s)

    Jointly provided by Global Learning Collaborative (GLC) and Total CME, LLC.

  • Commercial Support

    This activity is supported by independent educational grants from Astellas, US Independent Medical Education, and Pfizer Global Medical.

  • Instructions for Completion

    During the period 09/29/2023 through 09/29/2024, registered participants wishing to receive continuing education credit for this activity must follow these steps:
    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free